---
title: "Mizuho Securities Sticks to Their Buy Rating for Iovance Biotherapeutics (IOVA)"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/290454281.md"
description: "In a report released today, from Mizuho Securities maintained a Buy rating on Iovance Biotherapeutics, with a price target of $10.00.TipRanks' Prime Week Sale - 70% Off Unlock powerful investing tools and data-driven insights with TipRanks Premium for more confident investment decisions. Discover top stock picks and new investment opportunities through TipRanks' Smart Investor Newsletter. Iovance Biotherapeutics has an analyst consensus of Strong Buy, with a price target consensus of $9.80."
datetime: "2026-06-22T14:55:16.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/290454281.md)
  - [en](https://longbridge.com/en/news/290454281.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/290454281.md)
---

# Mizuho Securities Sticks to Their Buy Rating for Iovance Biotherapeutics (IOVA)

In a report released today, from Mizuho Securities maintained a Buy rating on Iovance Biotherapeutics, with a price target of $10.00.

### TipRanks' Prime Week Sale - 70% Off

-   Unlock powerful investing tools and data-driven insights with TipRanks Premium for more confident investment decisions.
-   Discover top stock picks and new investment opportunities through TipRanks' Smart Investor Newsletter.

Iovance Biotherapeutics has an analyst consensus of Strong Buy, with a price target consensus of $9.80.

### Related Stocks

- [IOVA.US](https://longbridge.com/en/quote/IOVA.US.md)
- [MFG.US](https://longbridge.com/en/quote/MFG.US.md)
- [8411.JP](https://longbridge.com/en/quote/8411.JP.md)

## Related News & Research

- [Is Iovance Biotherapeutics (IOVA) Undervalued On Q2 Earnings And Reaffirmed Guidance?](https://longbridge.com/en/news/295324260.md)
- [Iovance publishes corporate presentation highlighting Amtagvi TIL therapy rollout and pipeline expansion in solid tumors](https://longbridge.com/en/news/295105932.md)
- [Barclays Keeps Their Buy Rating on RWE AG (0HA0)](https://longbridge.com/en/news/295941081.md)
- [Jefferies Reaffirms Their Buy Rating on Pricesmart (PSMT)](https://longbridge.com/en/news/295817325.md)
- [Mizuho Securities Reaffirms Their Buy Rating on JD (JD)](https://longbridge.com/en/news/295947678.md)